Over the years, cancer researchers have uncovered many of the tricks that tumors use to fuel their growth and evade detection by the body’s immune system. More tricks await discovery, and finding t…
The NCI SBIR Innovation Lab podcast reaches and engages with entrepreneurs of all levels to share insights on commercialization and success stories from biotech industry…
The combination of Lonsurf and talazoparib (Talzenna) selectively killed cancer cells with mutations in the TP53 gene, researchers found in a study in mice.
Join fellow researchers, data scientists, and patient advocates in the quest to enhance today’s collection and exchange of standardized cancer data.
Overview The 12th Annual Symposium on Global Cancer Research (ASGCR) will be held virtually May 6 – May 9, 2024 [8AM-12PM Eastern Time each day]. See…
The NCCR*Explorer is an interactive data investigation tool from the NCI that leverages data from NCCR registries. It provides incidence and survival statistics for cancers…
Diversity in clinical trials is critical for understanding how well a treatment may work in different populations. A new study describes representation based on sex,…
Hailey, a survivor of Hodgkin lymphoma, believes sharing data can help doctors and researchers understand the unique needs of underserved groups.
A clinical trial that has been running for 30 years leads to a highly effective treatment for the rare precancerous condition lymphomatoid granulomatosis.
Explore the many ways you can participate in cancer research, including treatment and non-treatment studies.
An international team of researchers has identified 50 new areas across the genome that are associated with the risk of developing kidney cancer.
